NewLink Genetics Corporation (NLNK)

[Clonefan]

NewLink Genetics Corporation (NASDAQ:NLNK), a biopharmaceutical company at the forefront of developing and commercializing novel immuno-oncology product candidates to improve the lives of patients with cancer, announced today that it will participate in three upcoming investor conferences:

February 23, 2016 – SunTrust Orphan Drug Day 2016 at the JW Marriott Essex House in New York City.

February 23, 2016 – RBC Capital Markets Healthcare Conference. The presentation is at 10:30 a.m. EST at the New York Palace Hotel in New York City.

February 24, 2016 – the Company will participate in Citi’s Immunotherapy Bus Tour in New York City.